Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment

Revista Brasileira de Psiquiatria

Volumn 32, Issue 3, 2010, Pages 216-222

  Forlenza, Orestes V ^a   Diniz, Breno S ^a   Talib, Leda L ^a   Radanovic, Marcia ^a   Yassuda, Monica S ^a   Ojopi, Elida B ^a   Gattaz, Wagner F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alzheimer's disease; Biological indicators; Cognition disorders; Critical pathways; Neurobehavioral manifestations

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; GENOMIC DNA; MONOCLONAL ANTIBODY; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; GENOTYPE; HAMILTON SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; PREDICTION; PSYCHOLOGIC ASSESSMENT;

AGED; ALZHEIMER DISEASE; AMNESIA; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; COGNITION DISORDERS; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; TAU PROTEINS;

EID: 77958460898     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462010005000002     Document Type: Article

References (40)

1. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240-6.
2. Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr. 2004;16(2):128-40.
3. Hototian SR, Lopes MA, Azevedo D, Tatsch M, Bazzarella MC, Bustamante SEZ, Litvoc J, Bottino CMC. Prevalence of Cognitive and Functional Impairment in a Community Sample from São Paulo, Brazil. Dement Geriatr Cogn Disord. 2008;25(2):135-43.
4. Chaves ML, Camozzato AL, Godinho C, Piazenski I, Kaye J. Incidence of Mild Cognitive Impairment and Alzheimer Disease in Southern Brazil. J Geriatr Psychiatry Neurol. 2009;22(3):181-7.
5. Diniz BS, Yassuda MS, Nunes PV, Radanovic M, Forlenza OV. Mini-mental State Examination performance in mild cognitive impairment subtypes. Int Psychogeriatr. 2007;19(4):647-56.
6. Diniz BS, Nunes PV, Yassuda MS, Pereira FS, Flaks MK, Viola LF, Radanovic M, Abreu ID, Borelli DT, Gattaz WF, Forlenza OV. Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr. 2008;30(4):316-21.
7. Forlenza OV, Chiu E. Mild cognitive impairment: a concept ready to move on? Curr Opin Psychiatry. 2008;21(6):529-32.
8. Diniz BS, Nunes PV, Yassuda MS, Forlenza OV. Diagnosis of mild cognitive impairment revisited after one year: preliminary results of a prospective study. Dement Geriatr Cogn Disord. 2009;27(3):224-31.
9. Busse A, Hensel A, Gühne U, Angermeyer MC, Riedel-Heller SG. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology. 2006;67(12):2176-85. (Pubitemid 46035473)
10. Diniz BS, Pinto Jr. JA, Gonzaga ML, Guimarães FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 2009;259(4):248-56.
11. Nunes PV, Forlenza OV, Gattaz WF. Lithium and neuroprotection: new potential uses in psychiatry. Rev Psiq Clin. 2007;34(6):294-5.
12. Tyas SL, Salazar JC, Snowdon DA, Desrosiers MF, Riley KP, Mendiondo MS, Kryscio RJ. Transitions to Mild Cognitive Impairments, Dementia, and Death: Findings from the Nun Study. Am J Epidemiol. 2007;165(11):1231-8.
13. Rozzini L, Chilovi BV, Conti M, Bertoletti E, Delrio I, Trabucchi M, Padovani A. Conversion of amnestic Mild Cognitive Impairment to Dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry. 2007(12);22:1217-22. (Pubitemid 350285426)
14. Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, Corcoran C, Green RC, Hayden K, Norton MC, Zandi PP, Toone L, West NA, Breitner JC; Cache County Investigators. Conversion to dementia from mild cognitive disorder: The Cache County Study. Neurolog y. 2006;67(2):229-34. (Pubitemid 44305404)
15. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006;5(3):228-34. (Pubitemid 43238346)
16. Busatto GF, Diniz, BS, Zanetti, MV. Voxel-based morphometry in Alzheimer's disease. Expert Rev Neurother. 2008;8(11):1691-702.
17. Jack Jr. CR, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005;65(8):1227-31.
18. Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y, Matsuda H, NemotoK, Imabayashi E, Yamada M, Iwamoto T, Arima K, Asada T. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. NeuroImage. 2005;28(4):1014-21.
19. Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol. 2006;59(4):673-81.
20. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R. CAMDEX: a standardized instrument for the diagnosis of mental disorders in the elderly with special reference to early detection of dementia. Br J Psychiatry. 1986;149:698-709. (Pubitemid 17205276)
21. Bottino CM, Almeida OP, Tamai S, Forlenza OV, Scalco MZ, Carvalho IAM. Entrevista estruturada para diagnóstico de transtornos mentais em idosos. São Paulo: PROTER, Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da USP; 1999.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
23. Wilson B, Cockburn J, Baddeley AD. Rivermead behavioural memory test. Suffolk, England: Thames Valley Test Company; 1985.
24. Fuld P. Guaranteed stimulus processing in the evaluation of memory and learning. Cortex. 1980;16(2):255-71. (Pubitemid 11122367)
25. Flaks MK, Yassuda MS, Regina AC, Cid CG, Camargo CH, Gattaz WF, Forlenza OV. The Short Test (SKT). A cognitive performance a preliminary study in of its psychometric properties in Brazil. Int Psychogeriatr. 2006;18(1):121-33.
26. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19(4):1015-22.
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer disease: report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-44. (Pubitemid 14076461)
28. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-8. (Pubitemid 29120227)
29. Yassuda MS, Diniz BS, Flaks MK, Viola LF, Pereira FS, Nunes PV, Forlenza OV. Neuropsychological profile of Brazilian older adults with heterogeneous educational backgrounds. Arch Clin Neuropsychol. 2009;24(1):71-9.
30. Livak KJ. Allelic discrimination using fluorogenic probes and the 59 nuclease assay. Genet Anal. 1999;14(5-6):143-9.
31. Diniz BS, Pinto Júnior JA, Forlenza OV. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry. 2008;9(3):172-82.
32. Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol. 2007;6(6):501-12.
33. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119(4):252-65.
34. Petersen RC. MCI treatment trials: failure or not? Lancet Neurol. 2007;6(6):473-5.
35. Pereira FS, Yassuda MS, Oliveira AM, Forlenza OV. Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment. Int Psychogeriatr. 2008;20(6):1104-15.
36. Visser PJ, Sheltens P, Verhey FRJ. Do MCI criteria in drug trials accurately identify subjects with pre-dementia Alzheimer's disease? J Neurol Neurosurg Psychiatry. 2005;76(10):1348-54.
37. Engelborghs S, De Vreese K, Van de Casteele T, Vanderstichele H, Van Everbroeck B, Cras P, Martin J-J, Vanmechelen E, De Deyn PP. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol Aging. 2008:29(8):1143-59.
38. Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D. Heterogeneity of Brain Glucose Metabolism in Mild Cognitive Impairment and Clinical Progression to Alzheimer Disease. Arch Neurol. 2005;62(11):1728-33.
39. Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S. Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging. 2009;30(2):165-73.
40. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734-46.